Ken Fisher Celldex Therapeutics, Inc. Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 120,544 shares of CLDX stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,544
Previous 123,836
2.66%
Holding current value
$3.91 Million
Previous $5.2 Million
14.16%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$262 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$152 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$121 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$110 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$108 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.52B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...